Premenstrual syndrome: A mini review

Kessel, 2000, Premenstrual syndrome advances in diagnosis and treatment, Obstet. Gynecol. Clin. N. Am., 27, 625, 10.1016/S0889-8545(05)70160-1

Halbreich, 2007, Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies, Gynecol. Endocrinol., 23, 123, 10.1080/09513590601167969

Chung, 2014, Premenstrual syndrome and premenstrual dysphoric disorder in perimenopausal women, J. Menopausal Med., 20, 69, 10.6118/jmm.2014.20.2.69

Schmidt, 1998, Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome, N. Engl. J. Med., 338, 209, 10.1056/NEJM199801223380401

Huo, 2007, Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene, Biol. Psychiatry, 62, 925, 10.1016/j.biopsych.2006.12.019

Rapkin, 2009, Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness, Expert Rev. Pharmacoecon. Outcomes Res., 9, 157, 10.1586/erp.09.14

Dennerstein, 2009, Premenstrual symptoms—severity, duration and typology: an international cross-sectional study, Menopause Int., 15, 120, 10.1258/mi.2009.009030

O'Brien, 2011, Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus, Arch. Womens Ment. Health, 14, 13, 10.1007/s00737-010-0201-3

Pearlstein, 2005, Pretreatment pattern of symptom expression in premenstrual dysphoric disorder, J. Affect Disord., 85, 275, 10.1016/j.jad.2004.10.004

Endicott, 2006, Daily Record of Severity of Problems (DRSP): reliability and validity, Arch. Womens Ment. Health, 9, 41, 10.1007/s00737-005-0103-y

Halbreich, 2006, Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?, CNS Drugs, 20, 523, 10.2165/00023210-200620070-00001

ACOG Committee on Practice Bulletins-Gynecology, 2000, ACOG practice bulletin: No 15: premenstrual syndrome, Obstet. Gynecol., 95

Sayegh, 1995, The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome, Obstet. Gynecol., 86, 520, 10.1016/0029-7844(95)00246-N

Vishnupriya, 2011, Effects of aerobic exercise at different intensities in pre menstrual syndrome, J. Obstet. Gynaecol. India, 61, 675, 10.1007/s13224-011-0117-5

Lustyk, 2009, Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review, Arch. Womens Ment. Health, 12, 85, 10.1007/s00737-009-0052-y

Thys-Jacobs, 1998, Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group, Am. J. Obstet Gynecol., 179, 444, 10.1016/S0002-9378(98)70377-1

Kashanian, 2007, Pyridoxine (vitamin B6) therapy for premenstrual syndrome, Int. J. Gynaecol. Obstet., 96, 43, 10.1016/j.ijgo.2006.09.014

Girman, 2003, An integrative medicine approach to premenstrual syndrome, Am. J. Obstet. Gynecol., 188, S56, 10.1067/mob.2003.403

Zamani, 2012, Therapeutic effect of Vitex agnus castus in patients with premenstrual syndrome, Acta Med. Iran., 50, 101

Yonkers, 2005, Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder, Obstet. Gynecol., 106, 492, 10.1097/01.AOG.0000175834.77215.2e

Lopez, 2012, Oral contraceptives containing drospirenone for premenstrual syndrome, Cochrane Database Syst. Rev., 2, 10.1002/14651858.CD006586.pub4

Marjoribanks, 2013, Selective serotonin reuptake inhibitors for premenstrual syndrome, Cochrane Database Syst. Rev., 6, 10.1002/14651858.CD001396.pub3

Cunningham, 2009, Update on research and treatment of premenstrual dysphoric disorder, Harv. Rev. Psychiatry, 17, 120, 10.1080/10673220902891836

Dimmock, 2000, Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review, Lancet, 356, 1131, 10.1016/S0140-6736(00)02754-9

Shah, 2008, Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis, Obstet. Gynecol., 111, 1175, 10.1097/AOG.0b013e31816fd73b

Nevatte, 2013, ISPMD consensus on the management of premenstrual disorders, Arch. Womens Ment. Health, 16, 279, 10.1007/s00737-013-0346-y

Wyatt, 2004, The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysis, BJOG, 111, 585, 10.1111/j.1471-0528.2004.00135.x